Survival after neoadjuvant chemoradiotherapy for esophageal. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Esophagogastric Junction Lymph Nodes Larynx

Diseases50

Rectal Neoplasms Esophageal Neoplasms Adenocarcinoma Carcinoma, Squamous Cell Neoplasm Recurrence, Local Head and Neck Neoplasms Breast Neoplasms Nasopharyngeal Neoplasms Lung Neoplasms Lymphatic Metastasis Carcinoma, Non-Small-Cell Lung Hypopharyngeal Neoplasms Pancreatic Neoplasms Muscle Neoplasms Laryngeal Neoplasms Neoplasm, Residual Radiation Injuries Carcinoma Deglutition Disorders Uterine Cervical Neoplasms Oropharyngeal Neoplasms Stomach Neoplasms Neoplasm Metastasis Mucositis Neoplasm Invasiveness Urinary Bladder Neoplasms Disease Progression Anus Neoplasms Sarcoma Esophagitis Otorhinolaryngologic Neoplasms Carcinoma, Ductal, Breast Osteosarcoma Bone Neoplasms Pelvic Neoplasms Carcinoma, Lobular Brain Neoplasms Recurrence Carcinoma, Transitional Cell Leukopenia Carcinoma, Small Cell Radiation Pneumonitis Liver Neoplasms Stomatitis Postoperative Complications Neoplasms, Squamous Cell Voice Disorders Prostatic Neoplasms Neutropenia Pharyngeal Neoplasms

Chemicals and Drugs44

Fluorouracil Cisplatin Deoxycytidine Taxoids Antineoplastic Agents Paclitaxel Antimetabolites, Antineoplastic Carboplatin Doxorubicin Epirubicin Organoplatinum Compounds Fluorodeoxyglucose F18 Cyclophosphamide Leucovorin Tumor Markers, Biological Vinblastine Anthracyclines Radiopharmaceuticals Antibodies, Monoclonal, Humanized Radiation-Sensitizing Agents Receptor, erbB-2 Tegafur Oxonic Acid Hydroxyurea Ifosfamide Etoposide Mitomycin Ki-67 Antigen Receptors, Estrogen Biomarkers, Pharmacological Methotrexate Receptors, Progesterone Antineoplastic Agents, Hormonal Camptothecin Antineoplastic Agents, Alkylating Vincristine Bridged Compounds Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Dacarbazine Nitriles Androgen Antagonists Triazoles Flutamide

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Chemoradiotherapy Esophagectomy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Neoplasm Staging Survival Rate Disease-Free Survival Survival Analysis Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Kaplan-Meier Estimate Prognosis Radiotherapy Dosage Radiotherapy Dose Fractionation Follow-Up Studies Induction Chemotherapy Drug Administration Schedule Positron-Emission Tomography Preoperative Care Radiotherapy, Conformal Remission Induction Digestive System Surgical Procedures Cystectomy Organ Sparing Treatments Prospective Studies Lymph Node Excision Brachytherapy Proportional Hazards Models Predictive Value of Tests Gastrectomy Multivariate Analysis Radiotherapy, Intensity-Modulated Feasibility Studies Tomography, X-Ray Computed Multimodal Imaging Clinical Trials, Phase II as Topic Immunohistochemistry Randomized Controlled Trials as Topic Tumor Burden Pneumonectomy Clinical Trials as Topic Salvage Therapy Treatment Failure Radiotherapy, High-Energy Risk Assessment Postoperative Care Neoplasm Grading Laryngectomy Patient Selection Risk Factors Cohort Studies Radiation Dosage Magnetic Resonance Imaging Mastectomy Lymphatic Irradiation Infusions, Intravenous Transplantation, Autologous Biopsy Maximum Tolerated Dose Probability Endosonography Clinical Trials, Phase III as Topic Dose-Response Relationship, Radiation Bone Marrow Transplantation Mastectomy, Segmental Postoperative Period Bone Marrow Purging Sensitivity and Specificity

Phenomena and Processes11

Cell Survival Time Factors Graft Survival Radiation Dosage Gene Expression Regulation, Neoplastic Maximum Tolerated Dose Probability Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Apoptosis Sensitivity and Specificity

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care29

Treatment Outcome Survival Rate Disease-Free Survival Survival Analysis Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Preoperative Care Prospective Studies Proportional Hazards Models Radiation Injuries Predictive Value of Tests Multivariate Analysis Feasibility Studies Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic Clinical Trials as Topic Treatment Failure Risk Assessment Postoperative Care Patient Selection Risk Factors Cohort Studies Radiation Dosage Probability Clinical Trials, Phase III as Topic Dose-Response Relationship, Radiation Postoperative Period Sensitivity and Specificity

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Chemoradiotherapy Esophagectomy Rectal Neoplasms Radiotherapy, Adjuvant Esophageal Neoplasms Chemotherapy, Adjuvant Combined Modality Therapy Fluorouracil Treatment Outcome Neoplasm Staging Survival Rate Adenocarcinoma Disease-Free Survival Carcinoma, Squamous Cell Survival Analysis Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Retrospective Studies Kaplan-Meier Estimate Prognosis Cisplatin Radiotherapy Dosage Head and Neck Neoplasms Cell Survival Deoxycytidine Taxoids Antineoplastic Agents Radiotherapy Breast Neoplasms Dose Fractionation Nasopharyngeal Neoplasms Follow-Up Studies Paclitaxel Antimetabolites, Antineoplastic Lung Neoplasms Induction Chemotherapy Carboplatin Doxorubicin Drug Administration Schedule Positron-Emission Tomography Preoperative Care Epirubicin Lymphatic Metastasis Survival Organoplatinum Compounds Fluorodeoxyglucose F18 Time Factors Radiotherapy, Conformal Remission Induction Carcinoma, Non-Small-Cell Lung Cyclophosphamide Hypopharyngeal Neoplasms Digestive System Surgical Procedures Leucovorin Pancreatic Neoplasms Cystectomy Esophagogastric Junction Organ Sparing Treatments Tumor Markers, Biological Prospective Studies Muscle Neoplasms Lymph Node Excision Brachytherapy Proportional Hazards Models Laryngeal Neoplasms Neoplasm, Residual Radiation Injuries Carcinoma Predictive Value of Tests Deglutition Disorders Gastrectomy Multivariate Analysis Vinblastine Uterine Cervical Neoplasms Oropharyngeal Neoplasms Anthracyclines Radiopharmaceuticals Graft Survival Radiotherapy, Intensity-Modulated Feasibility Studies Antibodies, Monoclonal, Humanized Tomography, X-Ray Computed Radiation-Sensitizing Agents Stomach Neoplasms Neoplasm Metastasis Receptor, erbB-2 Mucositis Neoplasm Invasiveness Tegafur Oxonic Acid Multimodal Imaging Clinical Trials, Phase II as Topic Immunohistochemistry Hydroxyurea Randomized Controlled Trials as Topic Urinary Bladder Neoplasms Ifosfamide Tumor Burden

No FAQ available that match "survival after neoadjuvant chemoradiotherapy for esophageal"